GMHPX
Price
$12.92
Change
-$0.01 (-0.08%)
Updated
Sep 5 closing price
Net Assets
434.97M
VIVIX
Price
$71.19
Change
-$0.23 (-0.32%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

GMHPX vs VIVIX

Header iconGMHPX vs VIVIX Comparison
Open Charts GMHPX vs VIVIXBanner chart's image
Goldman Sachs Rising Dividend Gr P
Price$12.92
Change-$0.01 (-0.08%)
VolumeN/A
Net Assets434.97M
Vanguard Value Index I
Price$71.19
Change-$0.23 (-0.32%)
VolumeN/A
Net Assets202.84B
GMHPX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GMHPX vs. VIVIX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMHPX is a StrongBuy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 203B vs. GMHPX (435M). VIVIX pays higher dividends than GMHPX: VIVIX (2.11) vs GMHPX (1.55). GMHPX was incepted earlier than VIVIX: GMHPX (7 years) vs VIVIX (27 years). GMHPX (0.90) is less costly to investors than VIVIX (0.04). GMHPX is a more actively managed with annual turnover of: 42.00 vs. VIVIX (9.00). GMHPX has a lower initial minimum investment than VIVIX: GMHPX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 7.74 vs. GMHPX (-3.13). VIVIX return over 5 years is better than : 70.16 vs. GMHPX (35.97).
GMHPXVIVIXGMHPX / VIVIX
Total Expense Ratio0.680.041,700%
Annual Report Gross Expense Ratio0.900.042,250%
Fund Existence7 years27 years-
Gain YTD6.7107.86685%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets435M203B0%
Annual Yield % from dividends1.552.1173%
Returns for 1 year-3.137.74-40%
Returns for 3 years11.1836.6131%
Returns for 5 years35.9770.1651%
Returns for 10 yearsN/A131.61-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XRTX0.820.01
+1.85%
XORTX Therapeutics
CPT111.361.02
+0.92%
Camden Property Trust
TMCI7.17N/A
N/A
Treace Medical Concepts
AGIO36.01-0.12
-0.33%
Agios Pharmaceuticals
ZENV1.51-0.05
-3.21%
Zenvia